An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients

Schizophrenia Bulletin

Volumn 22, Issue 4, 1996, Pages 597-609

  Stanley, Jeff A ^b   Williamson, Peter C ^a,c   Drost, Dick J ^c   Rylett, R Jane ^c   Carr, Tom J ^c   Malla, Ashok ^c   Thompson, R Terry ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; BRAIN LEVEL; CELL LOSS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; NERVE CELL LESION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCHIZOPHRENIA;

EID: 0029959563     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.4.597     Document Type: Review

References (60)

1. Andreasen, N. Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: The University of Iowa, 1984a.
2. Andreasen, N. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: The University of Iowa, 1984b.
3. Arnold, D.L.; Matthews, P.M.; Francis, G.; and Antel, J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease. Magnetic Resonance in Medicine, 14:154-159, 1990.
4. 1H NMR spectrum of rat brain. Magnetic Resonance in Medicine, 30:38-44, 1993.
5. 1H NMR spectra of human brain. Magnetic Resonance in Medicine, 32:294-302, 1994.
6. 1H-NMR spectroscopic studies of brain. Neuroscience and Biobehavioral Reviews, 13:23-31, 1989.
7. Bottomley, P.A. Human in vivo NMR spectroscopy in diagnostic medicine: Clinical tool or research probe? Radiology, 170:1-15, 1989.
8. Breier, A.; Buchanan, R.W.; Elkashef, A.; Munson, R.C.; Kirkpatrick, B.; and Gellad, F. Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Archives of General Psychiatry, 49:921-926, 1992.
9. Buchanan, R.W.; Breier, A.; Kirkpatrick, B.; Elkashef, A.; Munson, R.C.; Gellad, F.; and Carpenter, W.T., Jr. Structural abnormalities in deficit and nondeficit schizophrenia. American Journal of Psychiatry, 150:59-66, 1993.
10. Buckley, P.F.; Moore, C.; Long, H.; Larkin, C.; Thompson, P.; Mulvany, F.; Stack, J.P.; Ennis, J.T.; and Waddington, J.L. H-1 magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biological Psychiatry, 36:792-800, 1994.
11. Buchsbaum, M.S. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin, 16(3):379-389, 1990.
12. Calabrese, G.; Deicken, R.F.; Fein, G.; Merrin, E.L.; Schoenfeld, F.; and Weiner, M.W. 31-Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry, 32:26-32, 1992.
13. Carlsson, M., and Carlsson, A. Schizophrenia: A subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin, 16(3):425-432, 1990.
14. Cendes, F.; Andermann, F.; Preul, M.C.; and Arnold, D.L. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Annals of Neurology, 35:211-216, 1994.
15. 1H-MRS using water as an internal standard. Magnetic Resonance Imaging, 11:107-118, 1993.
16. Daly, D.A., and Moghaddam, B. Actions of clozapine and haloperidol on extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neuroscience Letters, 152:61-64, 1993.
17. 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting. Magnetic Resonance in Medicine, 15:305-319, 1990.
18. de Graaf, A.A.; van Dijk, J.E.; and Bovee, W.M.M.J. QUALITY: Quantification improvement by converting lineshapes to the Lorentzian type. Magnetic Resonance in Medicine, 13:343-357, 1990.
19. De Stefano, N.; Matthews, P.M.; and Arnold, D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magnetic Resonance in Medicine, 34:721-727, 1995.
20. Deutsch, S.I.; Mastropaolo, J.; Schwartz, B.L.; Rosse, R.B.; and Morihisa, J.M. A glutamatergic hypothesis of schizophrenia: Rationale for pharmacotherapy with glycine. Clinical Neuropharmacology, 12:1-13, 1989.
21. Erecinska, M., and Silver, I.A. Metabolism and role of glutamate in mammalian brain. Progress in Neurobiology, 35:245-296, 1990.
22. 1H spectroscopy of the human brain. NMR in Biomedicine, 2:216-224, 1989.
23. Ferrige, A.G., and Lindon, J.C. Resolution enhancement in FT NMR through the use of a double exponential function. Journal of Magnetic Resonance, 31:337-340, 1978.
24. Frahm, J.; Bruhn, H.; Gyngell, M.L.; Merboldt, K.D.; Hanicke, W.; and Sauter, R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo. Magnetic Resonance in Medicine, 9:79-93, 1989.
25. Frahm, J.; Michaelis, T.; Merboldt, K.D.; Bruhn, H.; Gyngell, M.L.; and Hanicke, W. Improvements in localized proton NMR spectroscopy of human brain and water suppression, short echo times, and 1 ml resolution. Journal of Magnetic Resonance, 90:464-473, 1990.
26. Graham, G.D.; Blamire, A.M.; Howseman, A.M.; Rothman, D.L.; Fayad, P.B.; Brass, L.M.; Petroff, O.A.; Shulman, R.G.; and Prichard, J.W. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke, 23:333-340, 1992.
27. Haase, A., and Frahm, J. Multiple chemical-shift-selective NMR imaging using stimulated echoes. Journal of Magnetic Resonance, 64:94-102, 1985.
28. Hanicke, W.; Michaelis, T.; Merboldt, K.D.; and Frahm, J. On the use of a fully automated data analysis method for in vivo MRS: Metabolite concentrations and relaxation times from proton spectra of human brain. In: Proceedings of the 12th Annual Meeting of the Society of Magnetic Resonance in Medicine. Berkeley Springs, CA: Society of Magnetic Resonance in Medicine, 1993. p. 977.
29. Harrison, P.J.; McLaughlin, D.; and Kerwin, R.W. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet, 337:450-452, 1991.
30. Javitt, D.C., and Zukin, S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry, 148:1301-1308, 1991.
31. Kauppinen, R.A.; Kokko, H.; and Williams, S.R. Detection of mobile proteins by proton nuclear magnetic resonance spectroscopy in the guinea pig brain ex vivo and their partial purification, Journal of Neurochemistry, 58:967-974, 1992.
32. 1H nuclear magnetic resonance spectroscopy in cortical brain slices from the guinea pig: Evidence for changes in detectability during severe anoxic insults. Journal of Neurochemistry, 57:1136-1144, 1991.
33. Kauppinen, R.A.; Williams, S.R.; Busza, A.L.; and van Bruggen, N. Applications of magnetic resonance spectroscopy and diffusion-weighted imaging to the study of brain biochemistry and pathology. Trends in Neuroscience, 16:88-95, 1993.
34. Klunk, W.E.; Panchalingam, K.; Mossy, J.; McClure, R.J.; and Pettegrew, J.W. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology, 42:1578-1585, 1992.
35. Krystal, J.H.; Karper, L.R.; Seibyl, J.P.; Freeman, G.K.; Delaney, R.; Bremner, J.D.; Heninger, G.R.; Bowers, M.B.; and Charney, D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Archives of General Psychiatry, 51:199-214, 1994.
36. Marquardt, D.W. An algorithm for least-squares estimation of non-linear parameters. Society of Industrial and Applied Mathematics Journal, 11:431-441, 1963.
37. Matalon, R.; Michals, K.; Sebesta, D.; Deanching, M.; Gashkoff, P.; and Casanova, J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. American Journal of Medical Genetics, 29:463-471, 1988.
38. Menon, D.K.; Baudouin, C.J.; Tomlinson, D.; and Hoyle, C. Proton MR spectroscopy and imaging of the brain in AIDS: Evidence of neuronal loss in regions that appear normal with imaging. Journal of Computer Assisted Tomography, 14:882-885, 1990.
39. Nasrallah, H.A.; Skinner, T.E.; Schmalbrock, P.; and Robitaille, P.M. Proton magnetic resonance spectroscopy (H-1 MRS) of the hippocampal formation in schizophrenia: A pilot study. British Journal of Psychiatry, 165:481-485, 1994.
40. Nicholls, D., and Attwell, D. The release and uptake of excitatory amino acids. Trends in Pharmacological Sciences, 11:462-468, 1990.
41. 31P magnetic resonance spectroscopy. Biological Psychiatry, 29:1149-1152, 1991.
42. Pehek, E.A.; Yamamoto, B.K.; and Meltzer, H.Y. The effects of clozapine on dopamine, 5-HT, and glutamate release in the rat medial prefrontal cortex. Schizophrenia Research, 4:323, 1991.
43. Pellerin, L., and Magistretti, P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis - A mechanism coupling neuronal activity to glucose utilization. Proceedings of the National Academy of Sciences of the United States of America, 91:10625-10629, 1994.
44. Perry, T.L.; Hansen, S.; Berry, K.; Mok, C.; and Lesk, D. Free amino acids and related compounds in biopsies of human brain. Journal of Neurochemistry, 18:521-528, 1971.
45. Pettegrew, J.W.; Keshavan, M.S.; Panchalingam, K.; Strychor, S.; Kaplan, D.B.; Tretta, M.G.; and Allen, M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics: A pilot study of the dorsolateral prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Archives of General Psychiatry, 48:563-568, 1991.
46. Provencher, S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine, 30:672-679, 1993.
47. Renshaw, P.F.; Yurgelun-Todd, D.A.; Tohen, M.; Gruber, S.; and Cohen, B.M. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry, 152:444-446, 1995.
48. Sharma, R.; Venkatasubramanian, P.N.; Barany, M.; and Davis, J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research, 8:43-49, 1992.
49. Sherman, A.D.; Davidson, A.T.; Baruah, S.; Hegwood, T.S.; and Waziri, R. Evidence of glutamatergic deficiency in schizophrenia. Neuroscience Letters, 121:77-80, 1991.
50. Spitzer, R., and Williams, J. Structured Clinical Interview for DSM-III-R, New York, NY: New York Psychiatric Institute, 1985.
51. 1H MR spectra. Magnetic Resonance in Medicine, 34:17-24, 1995a.
52. Stanley, J.A.; Williamson, P.C.; Drost, D.J.; Carr, T.J.; Rylett, R.J.; Malla, A.; and Thompson, R.T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Archives of General Psychiatry, 52:399-406, 1995b.
53. Stanley, J.A.; Williamson, P.C.; Drost, D.J.; Carr, T.J.; Rylett, R.J.; and Merskey, H. "In Vivo Proton MRS in Never Treated Schizophrenics." Presented at the Annual Meeting of the American Psychiatric Association, Washington, DC, May 1992.
54. Stanley, J.A.; Williamson, P.C.; Drost, D.J.; Carr, T.J.; Rylett, R.J.; and Thompson, R.T. Membrane phospholipid metabolism and schizophrenia: An in vivo P-31-MR spectroscopy study. Schizophrenia Research, 13:209-215, 1994.
55. Tallan, H.H. Studies on the distribution of N-acetyl-L-aspartic acid in brain. Journal of Biological Chemistry, 224:41-45, 1957.
56. Ułas, J., and Cotman, C.W. Excitatory amino acid receptors in schizophrenia. Schizophrenia Bulletin, 19(1):105-117, 1993.
57. Urenjak, J.; Williams, S.R.; Godown, D.G.; and Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience, 13:981-989, 1993.
58. Wachtel, H., and Turski, L. Glutamate: A new target in schizophrenia? Trends in Pharmacological Sciences, 11:219-220, 1990.
59. Yamamoto, B.K., and Cooperman, M.A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. Journal of Neuroscience, 14:4159-4166, 1994.
60. Zipursky, R.B.; Lim, K.O.; Sullivan, E.V.; Brown, B.W.; and Pfefferbaum, A. Widespread cerebral gray matter volume deficits in schizophrenia. Archives of General Psychiatry, 49:195-205, 1992.